SMART Trial for Medication Assisted Treatment Adherence

SMART Trial for Medication Assisted Treatment Adherence

Publication date: Sep 06, 2019

The purpose of this study is to compare the effectiveness of two different interventions for medication-assisted treatment (MAT) adherence: Contingency Management (CM) and Brief Motivational Intervention plus Substance Free Activities Session (BMI+SFAS).

Concepts Keywords
BMI Opioids
Buprenorphine Drugs
CM Organic compounds
Factorial RTT
Naloxone Morphinans
Opioid Tertiary alcohols
Randomized Trial Clinical pharmacology
Tailor Drug rehabilitation
Telephone Adherence
Tennessee Buprenorphine
Naloxone

Semantics

Type Source Name
disease MESH Substance-Related Disorders
gene UNIPROT NR4A2
gene UNIPROT ALG3
drug DRUGBANK Naloxone
drug DRUGBANK Buprenorphine
drug DRUGBANK Ilex paraguariensis leaf
gene UNIPROT ACAT1

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *